Expression of the mdr1 and mdr3 gene products in acute and chronic leukemias
- 1 April 1997
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 21 (4) , 313-319
- https://doi.org/10.1016/s0145-2126(96)00130-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseasePublished by Elsevier ,1993
- Preparation and Characterization of a Murine Monoclonal Antibody (MDR3M) Reactive withmdr3Gene ProductJapanese Journal of Cancer Research, 1992
- Overexpression of multidrug resistance‐associated p170‐glycoprotein in acute non‐lymphocytic leukemiaEuropean Journal of Haematology, 1992
- Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by CyclosporineJNCI Journal of the National Cancer Institute, 1990
- Expression of themdr3 gene in prolymphocytic leukemia: Association with cyclosporin-a-induced increase in drug accumulationInternational Journal of Cancer, 1990
- Effects of cyclosporin a and verapamil on the intracellular daunorubicin accumulation in chinese hamster ovary cells with increasing levels of drug‐resistanceInternational Journal of Cancer, 1989
- A rapid and sensitive flow cytometric method for the detection of multidrug‐resistant cellsCytometry, 1989
- Mode of action of calcium antagonists which alter anthracycline resistanceBiochemical Pharmacology, 1984